Lyra Therapeutics (LYRA) Q4 2024 Earnings

12NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-0.74
-0.55
-0.37
-0.18

Details

Expected EPS
-0.215
Actual EPS
-0.18
Surprise EPS
0.04
Surprise Percent
+16.28%

Description

Lyra Therapeutics (LYRA) has reported earnings of -0.18 per share for Q4 2024.

0 Comments

Share your thoughts